Why the study?
Evidence regarding the effectiveness of cardiac rehabilitation programs on medication adherence was conflicting.
Do cardiac rehabilitation programs improve medication adherence in patients with cardiovascular disease?
Population
16,677 participants with cardiovascular disease across 33 studies
Comparison
Cardiac rehabilitation programs vs standard care
Design
Systematic review and meta-analysis of randomised controlled trials and quasi-experimental studies
Key result
Cardiac rehabilitation programs increased medication adherence by 14% compared to standard care (RR 1.14; 95% CI 1.07 to 1.22; p=0.0002).
Authors
Loading...
Supports cardiac rehabilitation referral to boost adherence in CVD; confirms meta-analytic benefits on outcomes.
Meta-Analysis (n=16,677)
Do cardiac rehabilitation programs improve medication adherence in patients with cardiovascular disease?
Relative Risk: 1.14 (95% CI 1.07–1.22)
p-value: p=0.0002
Cardiac rehabilitation programs significantly improve medication adherence, quality of life, and reduce mortality and healthcare utilization in patients with cardiovascular disease, though evidence certainty for adherence is low.
Gebremichael et al. (2023) conducted a meta-analysis in cardiovascular disease (n=16,677). Cardiac rehabilitation programs vs. standard care was evaluated on medication adherence (RR 1.14, 95% CI 1.07 to 1.22, p=0.0002). Cardiac rehabilitation programs increased medication adherence by 14% compared to standard care (RR 1.14; 95% CI 1.07 to 1.22; p=0.0002).